vTv Therapeutics (VTVT) Short-Term Debt issuances (2017)
vTv Therapeutics' (VTVT) quarterly Short-Term Debt issuances came in at $7.5 million in Q1 2017.
Analysis
vTv Therapeutics (VTVT) Short-Term Debt issuances (2017) Analysis & Trends
vTv Therapeutics has disclosed Short-Term Debt issuances across 1 years of filings, most recently posting $7.5 million for Q1 2017.
- In Q1 2017, Short-Term Debt issuances changed N/A year-over-year to $7.5 million; the TTM figure through Dec 2017 stood at $7.5 million (changed N/A YoY), while the FY2017 annual figure was $7.5 million, down 40.0% from the prior year.
- Short-Term Debt issuances came in at $7.5 million for Q1 2017 at vTv Therapeutics.
- In the past five years, Short-Term Debt issuances ranged from a high of $7.5 million in Q1 2017 to a low of $7.5 million in Q1 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 707.00 Mn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | - |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 4.94 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 208.00 Mn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 64.00 Mn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | - |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | - |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - | - |